… Research Institutes Appoints Rebecca Li Ph.D. as VP of…
The News Review:
- … Research Institutes Appoints Rebecca Li Ph.D. as VP of…
- More Elderly Americans Living With Heart Failure But Heart Failure…
- Bloomberg.com: Investment Tools
- New Bladder Cancer Therapy For Patients Unresponsive To Standard…
- National Jewish Medical and Research Center Denver C
- Penn State Milton S. Hershey Medical Center Hershey Pennsylvania
- FDA and Disk Maker Questioned
… Research Institutes Appoints Rebecca Li Ph.D. as VP of…
Free with registration – Wireless News – AccessMyLibrary.com – Feb 27, 2008
com New England Research Institutes a privately held specialty Contract Research rganization (CR) announced the promotion of Rebecca Li Ph. to Vice President of Clinical Research. In the position Dr. Li and her team will collaborate to further establish NERI as a private sector CR servicing pharmaceutical biotechnology biomaterial.
More Elderly Americans Living With Heart Failure But Heart Failure…
Science Daily – Science Daily (press release) – Feb 27, 2008
Nearly a third of those diagnosed with heart failure will die within one year and "that figure hasn’t budged over the last decade" according to Curtis who is also a member of the Duke Clinical Research Institute. Journal reference: Arch Intern Med. 2008;168[4]:418-424Duke researchers contributing to the study include Drs. David Whellan Adrian Hernandez and Kevin Schulman from the Duke Clinical Research Center and Bradley Hammill Kevin Anstrom and Alisa Shea from the Center for Clinical and Genetic Economics. The study was funded by grants from the National Institute on Aging the National Heart Lung and Blood Institute and the Agency for Healthcare Research and Quality. Adapted from materials provided by.
Bloomberg.com: Investment Tools
Bloomberg – Feb 27, 2008
Lesniak has served as President and CE ofLesniak & Associates a medical device consulting firm focused onbusiness and market development for emerging technologies. In thiscapacity Ms. She is alsoexperienced in the design and implementation of clinical researchstudies and investigational plans. Lesniak is an acting VicePresident at several early stage medical device companies.
New Bladder Cancer Therapy For Patients Unresponsive To Standard…
Medical News Today – Medical News Today (press release) – Feb 27, 2008
When this happens typically their only option is surgical removal of the bladder. Now researchers at the Herbert Irving Comprehensive Cancer Center of NewYork-Presbyterian Hospital and Columbia University Medical Center are investigating an FDA-approved metastatic breast-cancer drug called Abraxane® that may prove a safe and effective alternative to surgery for these patients. Bladder cancer is the fourth leading cause of cancer in men and the ninth leading cause of cancer in women in the United States. In a given year more than 60000 new cases are diagnosed and 13000 will die from the disease. “When the standard treatment does not work currently the only option is surgical removal of the bladder — something that for all patients is unappealing and for some sicker patients is not even possible. With this study we hope to find an effective second line medical option for these patients” says Dr.
National Jewish Medical and Research Center Denver C
ABC News – Feb 27, 2008
Erwin Gelfand n Allergy Research At National Jewish Medical and Research CenterErwin Gelfand M. Chairman of Pediatrics National Jewish Medical and Research CenterFebruary 27 2008.
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania
ABC News – Feb 27, 2008
Timothy Craig n Asthma Research At Penn State Hershey College of MedicineWe also have multiple clinical studies going and we also have an up-to-date laboratory that studies obstructive lung disease and a clinic that is up-to-date. In addition we’re part of a large consortium sponsored by the National Institutes of Health to study asthma. It’s called the Asthma Clinical Research Network and it’s some of the finest researchers in the world that are participating in this experiment to determine how patients respond to medications and why.
FDA and Disk Maker Questioned
New York Times – Feb 27, 2008
Food And Drug Administration. approval of the device. Skip to next paragraph Related.
Written by admin on February 27th, 2008 with
no comments.
Read more articles on News.